By Professor Bruce James Brew

Journal articles

Brew B; Faux SG; Blanchard E, 2022, 'Effectiveness of a Smartwatch App in Detecting Induced Falls: Observational Study', Jmir Formative Research, 6, http://dx.doi.org/10.2196/30121

Brew BJ, 2022, 'Is HIV Brain Disease Preventable?', Neurology(R) neuroimmunology & neuroinflammation, 9, http://dx.doi.org/10.1212/NXI.0000000000001145

Chatterton S; Dwyer L; Thomson C; Plit M; Longmuir H; Chaganti J; Barnett Y; Brew B, 2022, 'Atypical presentations and course of JC virus infection', Journal of Neurovirology, 28, pp. 183 - 186, http://dx.doi.org/10.1007/s13365-021-01031-6

Bukhari W; Khalilidehkordi E; Mason DF; Barnett MH; Taylor BV; Fabis-Pedrini M; Kermode AG; Subramanian S; Waters P; Broadley SA; Broadley SA; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brilot F; Brownlee WJ; Bundell CS; Butzkueven H; Carroll WM; Chen C; Clarke L; Coulthard A; Dale RC; Das C; Dear K; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez Sanchez S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell RAL; Marriott MP; McCombe PA; O’Gorman C; Parratt JDE; Pender MP; Pereira J; Pollard JD; Prain KM; Ramanathan S; Reddell SW; Shaw C; Silvestrini RA; Slee M; Spies J; Stankovich J; Sutton I; Vincent A; Vucic S; Walsh M; Willoughby E; Wong RC; Woodhall M; Yiu EM, 2022, 'NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand', Journal of Neurology, 269, pp. 836 - 845, http://dx.doi.org/10.1007/s00415-021-10665-9

Sundaram G; Bessede A; Gilot D; Staats Pires A; Sherman LS; Brew BJ; Guillemin GJ, 2022, 'Prophylactic and Therapeutic Effect of Kynurenine for Experimental Autoimmune Encephalomyelitis (EAE) Disease', International Journal of Tryptophan Research, 15, http://dx.doi.org/10.1177/11786469221118657

Anesten B; Zetterberg H; Nilsson S; Brew BJ; Fuchs D; Price RW; Gisslén M; Yilmaz A, 2021, 'Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection', BMC Neurology, 21, http://dx.doi.org/10.1186/s12883-021-02527-8

Chaganti J; Brew BJ, 2021, 'MR spectroscopy in HIV associated neurocognitive disorder in the era of cART: a review', AIDS Research and Therapy, 18, http://dx.doi.org/10.1186/s12981-021-00388-2

Suzuki K; Levert A; Yeung J; Starr M; Cameron J; Williams R; Rismanto N; Stark T; Druery D; Prasad S; Ferrarini C; Hanafi I; McNally LP; Cunningham P; Liu Z; Ishida T; Huang CS; Oswald V; Evans L; Symonds G; Brew BJ; Zaunders J, 2021, 'HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity', AIDS, 35, pp. 2095 - 2103, http://dx.doi.org/10.1097/QAD.0000000000003001

Darley DR; Dore GJ; Byrne AL; Plit ML; Brew BJ; Kelleher A; Matthews GV, 2021, 'Limited recovery from post-acute sequelae of sars-cov-2 at 8 months in a prospective cohort', Erj Open Research, 7, http://dx.doi.org/10.1183/23120541.00384-2021

Clarke L; Arnett S; Bukhari W; Khalilidehkordi E; Jimenez Sanchez S; O'Gorman C; Sun J; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Abernethy DA; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Fabis-Pedrini MJ; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Ramanathan S; Reddel SW; Shaw CP; Spies JM; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AGK; Marriott MP; Parratt JDE; Slee M; Taylor BV; Willoughby E; Brilot F; Vincent A; Waters P; Broadley SA, 2021, 'MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis', Frontiers in Neurology, 12, http://dx.doi.org/10.3389/fneur.2021.722237

Brouillette MJ; Koski L; Forcellino L; Gasparri J; Brew BJ; Fellows LK; Mayo NE; Cysique LA, 2021, 'Predicting occupational outcomes from neuropsychological test performance in older people with HIV', AIDS, 35, pp. 1765 - 1774, http://dx.doi.org/10.1097/QAD.0000000000002927

Gates TM; Kamminga J; Jayewardene A; Vincent T; Quan D; Brew BJ; Bloch M; Cysique LA, 2021, 'Erratum: An examination of reliable change methods for measuring cognitive change with the cogstate computerized battery: Research and clinical implications (Archives of Clinical Neuropsychology (2021) DOI: 10.1093/arclin/acaa076)', Archives of Clinical Neuropsychology, 36, pp. 859, http://dx.doi.org/10.1093/arclin/acaa127

Gates TM; Kamminga J; Jayewardene A; Vincent T; Quan D; Brew BJ; Bloch M; Cysique LA, 2021, 'An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implications', Archives of Clinical Neuropsychology, 36, pp. 597 - 612, http://dx.doi.org/10.1093/arclin/acaa076

Clarke L; Arnett S; Bukhari W; Khalilidehkordi E; Sanchez SJ; O’Gorman C; Prain K; Woodhall M; Silvestrini R; Bundell C; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew B; Brownlee W; Butzkueven H; Carroll W; Chen C; Coulthard A; Dale R; Das C; Fabis-Pedrini M; Fulcher D; Gillis D; Hawke S; Heard R; Henderson A; Heshmat S; Hodgkinson S; Kilpatrick T; King J; Kneebone C; Kornberg A; Lechner-Scott J; Lin M-W; Lynch C; Macdonell R; Mason D; McCombe P; Pereira J; Pollard J; Ramanathan S; Reddel S; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong R; Yiu E; Barnett M; Kermode A; Marriott M; Parratt J; Slee M; Taylor B; Willoughby E; Brilot F; Vincent A; Waters P; Broadley S, 2021, 'MRI Patterns Distinguish Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis (4128)', Neurology, 96, http://dx.doi.org/10.1212/wnl.96.15_supplement.4128

Chaganti J; Woodford H; Tomlinson S; Dunkerton S; Brew B, 2021, 'Black blood imaging of intracranial vessel walls', Practical Neurology, 21, pp. 101 - 107, http://dx.doi.org/10.1136/practneurol-2020-002806

Darley D; Matthews G; Dore G; Wilhelm K; Plit M; Stone E; Byrne A; Tonga K; Andresen D; Kelleher A; Cysique L; Cunningham P; Brew B, 2021, 'Persistent symptoms up to four months after community and hospital- managed SARS- CoV- 2 infection', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50963

Aung HL; Bloch M; Vincent T; Quan D; Jayewardene A; Liu Z; Gates TM; Brew B; Mao L; Cysique LA, 2021, 'Cognitive ageing is premature among a community sample of optimally treated people living with HIV', HIV Medicine, 22, pp. 151 - 164, http://dx.doi.org/10.1111/hiv.12980

Vance DE; Brew BJ, 2021, 'HIV neurocognitive impairment and Alzheimer’s disease: Sniffing out the difference', AIDS, 35, pp. 511 - 513, http://dx.doi.org/10.1097/QAD.0000000000002731

Aung HL; Aghvinian M; Gouse H; Robbins RN; Brew BJ; Mao L; Cysique LA, 2021, 'Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review', AIDS and Behavior, 25, pp. 917 - 960, http://dx.doi.org/10.1007/s10461-020-03053-3

Nir TM; Fouche JP; Ananworanich J; Ances BM; Boban J; Brew BJ; Chaganti JR; Chang L; Ching CRK; Cysique LA; Ernst T; Faskowitz J; Gupta V; Harezlak J; Heaps-Woodruff JM; Hinkin CH; Hoare J; Joska JA; Kallianpur KJ; Kuhn T; Lam HY; Law M; Lebrun-Frénay C; Levine AJ; Mondot L; Nakamoto BK; Navia BA; Pennec X; Porges EC; Salminen LE; Shikuma CM; Surento W; Thames AD; Valcour V; Vassallo M; Woods AJ; Thompson PM; Cohen RA; Paul R; Stein DJ; Jahanshad N, 2021, 'Association of Immunosuppression and Viral Load with Subcortical Brain Volume in an International Sample of People Living with HIV', JAMA Network Open, 4, http://dx.doi.org/10.1001/jamanetworkopen.2020.31190

Angelovich TA; Churchill MJ; Wright EJ; Brew BJ, 2021, 'New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment', , 50, pp. 3 - 39, http://dx.doi.org/10.1007/7854_2019_126

Braidy N; Alicajic H; Pow D; Smith J; Jugder BE; Brew BJ; Nicolazzo JA; Guillemin GJ, 2021, 'Potential Mechanism of Cellular Uptake of the Excitotoxin Quinolinic Acid in Primary Human Neurons', Molecular Neurobiology, 58, pp. 34 - 54, http://dx.doi.org/10.1007/s12035-020-02046-6

Darley DR; Dore GJ; Byrne A; Plit M; Brew BJ; Kelleher A; Matthews GV, 2021, 'Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort', , http://dx.doi.org/10.1101/2021.03.29.21254211

Caffrey Osvald E; Bower H; Lundholm C; Larsson H; Brew BK; Almqvist C; Haasdyk BB, 2020, 'Asthma and all-cause mortality in children and young adults: A population-based study', Thorax, 75, pp. 1040 - 1046, http://dx.doi.org/10.1136/thoraxjnl-2020-214655

Calon M; Menon K; Carr A; Henry RG; Rae CD; Brew BJ; Cysique LA, 2020, 'Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV', Journal of Acquired Immune Deficiency Syndromes, 84, pp. 543 - 551, http://dx.doi.org/10.1097/QAI.0000000000002390

Howdle GC; Quidé Y; Kassem MS; Johnson K; Rae CD; Brew BJ; Cysique LA; Quide Y, 2020, 'Brain amyloid in virally suppressed HIV-associated neurocognitive disorder', Neurology Neuroimmunology and Neuroinflammation, 7, pp. e739, http://dx.doi.org/10.1212/NXI.0000000000000739

Khalilidehkordi E; Clarke L; Arnett S; Bukhari W; Jimenez Sanchez S; O'Gorman C; Sun J; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brown M; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Ramanathan S; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt J; Slee M; Taylor BV; Willoughby E; Brilot F; Vincent A; Waters P; Broadley SA, 2020, 'Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation', Frontiers in Neurology, 11, http://dx.doi.org/10.3389/fneur.2020.00537

Sundaram G; Lim CK; Brew BJ; Guillemin GJ, 2020, 'Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression', Journal of Neuroinflammation, 17, pp. 176, http://dx.doi.org/10.1186/s12974-020-01844-y

Bukhari W; Clarke L; O’Gorman C; Khalilidehkordi E; Arnett S; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Ramanathan S; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonnell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt J; Slee M; Taylor BV; Willoughby E; Wilson RJ; Brilot F; Vincent A; Waters P; Broadley SA, 2020, 'The clinical profile of NMOSD in Australia and New Zealand', Journal of Neurology, 267, pp. 1431 - 1443, http://dx.doi.org/10.1007/s00415-020-09716-4

Zeng G; Penninkilampi R; Chaganti J; Montagnese S; Brew BJ; Danta M, 2020, 'Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy', Neurology, 94, pp. e1147 - e1156, http://dx.doi.org/10.1212/WNL.0000000000008899

Brew BJ; McArthur JC, 2020, ''A man is as old as his arteries' (attributed to Thomas Sydenham, the English Hippocrates)', AIDS, 34, pp. 637 - 639, http://dx.doi.org/10.1097/QAD.0000000000002414

Situ Y; Subbiah R; Brew B; Holloway C, 2020, '243 Pilot Study of the Samsung S-patch for Cardiac Monitoring', Heart, Lung and Circulation, 29, pp. S143 - S143, http://dx.doi.org/10.1016/j.hlc.2020.09.250

Tun N; Chaganti J; Zeng G; Lockart I; Montagnese S; Brew B; Danta M, 2020, 'Prospective study of magnetic resonance spectroscopy identifies specific metabolic changes in covert hepatic encephalopathy', JOURNAL OF HEPATOLOGY, 73, pp. S737 - S737

Barnes SL; Brew BJ, 2019, 'Acute cerebellar ataxia after Epstein-Barr virus infection', Neurology Clinical Practice, 9, pp. 505 - 506, http://dx.doi.org/10.1212/CPJ.0000000000000659

Zhai S; McColl C; Mahajan A; Lueck CJ; Brew BJ, 2019, 'Recurrent HIV-associated posterior reversible encephalopathy syndrome', Neurology Clinical Practice, 9, pp. 478 - 480, http://dx.doi.org/10.1212/CPJ.0000000000000602

Brew BJ; Barnes SL, 2019, 'The impact of HIV central nervous system persistence on pathogenesis', AIDS, 33, pp. S113 - S121, http://dx.doi.org/10.1097/QAD.0000000000002251

Brew BJ; McArthur J, 2019, 'Distinguishing cognitive impairment from HIV-associated neurocognitive disorder versus substance use?', AIDS, 33, pp. 1943 - 1944, http://dx.doi.org/10.1097/QAD.0000000000002292

Chaganti J; Marripudi K; Staub LP; Rae CD; Gates TM; Moffat KJ; Brew BJ, 2019, 'Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications', AIDS, 33, pp. 1843 - 1852, http://dx.doi.org/10.1097/QAD.0000000000002300

Cysique LA; Brew BJ, 2019, 'Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm', Journal of Neurovirology, 25, pp. 710 - 721, http://dx.doi.org/10.1007/s13365-018-0706-5

Brew BJ; Paul R, 2019, 'HIV-associated neurocognitive disorder, extracellular vesicles and gender: Vive la difference?', AIDS, 33, pp. 1795 - 1796, http://dx.doi.org/10.1097/QAD.0000000000002273

Jacobs KR; Lim CK; Blennow K; Zetterberg H; Chatterjee P; Martins RN; Brew BJ; Guillemin GJ; Lovejoy DB, 2019, 'Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau', Neurobiology of Aging, 80, pp. 11 - 20, http://dx.doi.org/10.1016/j.neurobiolaging.2019.03.015

Aung HL; Kootar S; Gates TM; Brew BJ; Cysique LA, 2019, 'How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection?', European Geriatric Medicine, 10, pp. 227 - 238, http://dx.doi.org/10.1007/s41999-019-00164-6

Cysique LA; Jugé L; Lennon MJ; Gates TM; Jones SP; Lovelace MD; Rae CD; Johnson TP; Nath A; Brew BJ, 2019, 'HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection', AIDS, 33, pp. 433 - 441, http://dx.doi.org/10.1097/QAD.0000000000002076

Cysique LA; Brew BJ, 2019, 'Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection', , 165, pp. 71 - 82, http://dx.doi.org/10.1016/B978-0-444-64012-3.00006-X

Asahchop EL; Branton WG; Krishnan A; Chen PA; Yang D; Kong L; Zochodne DW; Brew BJ; Gill MJ; Power C, 2018, 'HIV-associated sensory polyneuropathy and neuronal injury are associated with miRNA-455-3p induction', Jci Insight, 3, http://dx.doi.org/10.1172/jci.insight.122450

Sutherland EJ; Brew BJ, 2018, 'Human Immunodeficiency Virus and the Nervous System', Neurologic Clinics, 36, pp. 751 - 765, http://dx.doi.org/10.1016/j.ncl.2018.07.002

Nichols M; Gates T; Soares J; Moffat K; Rae C; Brew B; Cysique L, 2018, 'Brain atrophic signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection', AIDS, 33, pp. 55 - 66, http://dx.doi.org/10.1097/QAD.0000000000002042

Wilson MR; O'Donovan BD; Gelfand JM; Sample HA; Chow FC; Betjemann JP; Shah MP; Richie MB; Gorman MP; Hajj-Ali RA; Calabrese LH; Zorn KC; Chow ED; Greenlee JE; Blum JH; Green G; Khan LM; Banerji D; Langelier C; Bryson-Cahn C; Harrington W; Lingappa JR; Shanbhag NM; Green AJ; Brew BJ; Soldatos A; Strnad L; Doernberg SB; Jay CA; Douglas V; Josephson SA; DeRisi JL, 2018, 'Chronic meningitis investigated via metagenomic next-generation sequencing', JAMA Neurology, 75, pp. 947 - 955, http://dx.doi.org/10.1001/jamaneurol.2018.0463

Anderson AM; Croteau D; Ellis RJ; Rosario D; Potter M; Guillemin GJ; Brew BJ; Woods SP; Letendre SL, 2018, 'HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau', Journal of Neuroimmunology, 319, pp. 13 - 18, http://dx.doi.org/10.1016/j.jneuroim.2018.03.007

Wright EJ; Grund B; Robertson KR; Cysique L; Brew BJ; Collins GL; Poehlman-Roediger M; Vjecha MJ; Penalva De Oliveira AC; Standridge B; Carey C; Avihingsanon A; Florence E; Lundgren JD; Arenas-Pinto A; Mueller NJ; Winston A; Nsubuga MS; Lal L; Price RW, 2018, 'No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts', AIDS, 32, pp. 985 - 997, http://dx.doi.org/10.1097/QAD.0000000000001778

Back to profile page